Omron Corp. (OTCMKTS:OMRNY – Get Free Report)’s stock price gapped down before the market opened on Thursday. The stock had previously closed at $41.11, but opened at $37.3650. Omron shares last traded at $37.40, with a volume of 2,155 shares.
Wall Street Analyst Weigh In
Separately, Zacks Research raised shares of Omron from a “strong sell” rating to a “hold” rating in a research note on Monday, August 10th. Two analysts have rated the stock with a Hold rating. Based on data from MarketBeat, the company currently has an average rating of “Hold”.
Get Our Latest Analysis on Omron
Omron Stock Down 5.6%
The company has a debt-to-equity ratio of 0.09, a current ratio of 1.93 and a quick ratio of 1.49. The stock has a 50 day simple moving average of $40.57 and a 200-day simple moving average of $36.48. The firm has a market cap of $7.74 billion, a PE ratio of 35.72, a PEG ratio of 0.80 and a beta of 1.22.
Hedge Funds Weigh In On Omron
A hedge fund recently raised its position in Omron stock. GAMMA Investing LLC raised its holdings in shares of Omron Corp. (OTCMKTS:OMRNY – Free Report) by 12.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 3,536 shares of the company’s stock after purchasing an additional 382 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $144,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 1.09% of the company’s stock.
About Omron
Omron Corporation is a Japan-based technology company that develops automation, sensing, control and healthcare solutions. Its products include industrial sensors, controllers, machine-vision and inspection systems, safety equipment, robotics and other factory-automation technologies used to improve manufacturing productivity and quality.
Through its healthcare business, Omron provides blood-pressure monitors, electrocardiographs, nebulizers, body-composition monitors and related digital health services for consumers and medical professionals.
Further Reading
- Five stocks we like better than Omron
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
- Fastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure
- Synopsys Signals Confidence With $1B Accelerated Buyback, Analysts Raise Targets
Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.
